Evidence map›Paper›PMID 23183491›Full record

Trial reportMolecular psychiatry2014

Genome-wide association study identifies a potent locus associated with human opioid sensitivity.

D Nishizawa, K Fukuda, S Kasai, J Hasegawa, Y Aoki, A Nishi, N Saita, Y Koukita, M Nagashima, R Katoh and 19 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biochemical Diagnosis in Substance and Non-substance Addiction.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. International journal of molecular sciences · 2024
    Article
  10. Single-Nucleotide Polymorphisms of theInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Article
  13. Genetic Polymorphisms ofInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Associations between thePharmaceutics · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 1 country.

D NishizawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
K FukudaDivision of Dental Anesthesiology, Department of Oral Health and Clinical Science, Orofacial Pain Center Suidoubashi Hospital, Tokyo Dental College, Tokyo, Japan.
S KasaiAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
J HasegawaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Y Aoki1] Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan [2] Division of Dental Anesthesiology, Department of Oral Health and Clinical Science, Orofacial Pain Center Suidoubashi Hospital, Tokyo Dental College, Tokyo, Japan.
A NishiAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
N SaitaDivision of Dental Anesthesiology, Department of Oral Health and Clinical Science, Orofacial Pain Center Suidoubashi Hospital, Tokyo Dental College, Tokyo, Japan.
Y KoukitaDivision of Dental Anesthesiology, Department of Oral Health and Clinical Science, Orofacial Pain Center Suidoubashi Hospital, Tokyo Dental College, Tokyo, Japan.
M NagashimaDepartment of Surgery, Toho University Sakura Medical Center, Sakura, Japan.
R KatohDepartment of Surgery, Toho University Sakura Medical Center, Sakura, Japan.
Y SatohDepartment of Anesthesiology, Toho University Sakura Medical Center, Sakura, Japan.
M TagamiDepartment of Anesthesiology, Toho University Sakura Medical Center, Sakura, Japan.
S HiguchiNational Hospital Organization, Kurihama Alcoholism Center, Yokosuka, Japan.
H UjikeUjike Nishiguchi Clinic, Okayama, Japan.
N OzakiDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
T InadaDepartment of Psychiatry, Seiwa Hospital, Institute of Neuropsychiatry, Tokyo, Japan.
N IwataDepartment of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.
I Sora1] Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan [2] Department of Psychobiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
M IyoDepartment of Psychiatry, Graduate School of Medicine, Chiba University, Chiba, Japan.
N KondoSeimei Hospital, Fuji City, Japan.
M-J WonKoujin Hospital, Nagoya, Japan.
N NaruseSaitama Seishin-iryo Center, Kita-adachi, Saitama, Japan.
K Uehara-AoyamaKanagawa-Kenritsu Seisin Iryo Senta Serigaya Byoin, Yokohama, Japan.
M ItokawaSchizophrenia and Depression Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
M KogaDepartrnent of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
T ArinamiDepartrnent of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan.
Y KanekoDivision of Dental Anesthesiology, Department of Oral Health and Clinical Science, Orofacial Pain Center Suidoubashi Hospital, Tokyo Dental College, Tokyo, Japan.
M HayashidaDepartment of Anesthesiology & Pain Medicine, Juntendo University School of Medicine, Tokyo, Japan.
K IkedaAddictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Tokyo Metropolitan Institute of Medical Science · JPTokyo Dental College · JPToho University Medical Center Sakura Hospital · JPUniversity of Tsukuba · JPChiba University · JPFujita Health University · JPJuntendo University · JPKoujin Hospital · JPNagoya University · JPNational Hospital Organization · JPSeiwa Hospital · JPTohoku University · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioids, such as morphine and fentanyl, are widely used as effective analgesics for the treatment of acute and chronic pain. In addition, the opioid system has a key role in the rewarding effects of morphine, ethanol, cocaine and various other drugs. Although opioid sensitivity is well known to vary widely among individual subjects, several candidate genetic polymorphisms reported so far are not sufficient for fully understanding the wide range of interindividual differences in human opioid sensitivity. By conducting a multistage genome-wide association study (GWAS) in healthy subjects, we found that genetic polymorphisms within a linkage disequilibrium block that spans 2q33.3-2q34 were strongly associated with the requirements for postoperative opioid analgesics after painful cosmetic surgery. The C allele of the best candidate single-nucleotide polymorphism (SNP), rs2952768, was associated with more analgesic requirements, and consistent results were obtained in patients who underwent abdominal surgery. In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects. Furthermore, the C/C genotype of this SNP was significantly associated with the elevated expression of a neighboring gene, CREB1. These results show that SNPs in this locus are the most potent genetic factors associated with human opioid sensitivity known to date, affecting both the efficacy of opioid analgesics and liability to severe substance dependence. Our findings provide valuable information for the personalized treatment of pain and drug dependence.

Indexed as

AdolescentAdultAgedAged, 80 and overAnalgesics, OpioidChromosomes, Human, Pair 2Cyclic AMP Response Element-Binding ProteinDNA Modification MethylasesFemaleGenome-Wide Association StudyGenotypeHumansLinkage DisequilibriumMaleMiddle AgedPain MeasurementAnalgesics, OpioidCREB1 protein, humanCyclic AMP Response Element-Binding ProteinDNA Modification MethylasesMETTL21A protein, human

Identifiers

PMID23183491
PMCPMC3873034
OpenAlexW1973065882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.